ボストン科学リズム管理レジストリ (SOCRATES) (SOCRATES)
ボストン科学リズム管理レジストリ
SOCRATES is part of Boston Scientific's (BSC) Post-market surveillance system. The implementation of such systems is mandatory per local regulations such as the Regulation '(EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices' or short Medical Device Regulation (MDR). The SOCRATES design is therefore based on the BSC's commitment as well as external regulatory requirements to proactively and systematically gather, record and analyze relevant data on the quality, performance and safety of devices throughout their entire lifetime.
調査の概要
詳細な説明
SOCRATES is a non-randomized, multisite, single-arm, open-label, global post-market observational data collection per standard of care. While generally of prospective design, a limited retrospective element is allowed for the inclusion of patients for a short period of 10 days after their index procedure.
SOCRATES intends to enroll a number of subjects that will support the analysis of all the individual Post Market Clinical Follow-Up (PMCF) Plans. An average of approximately 100 subjects per year and site on a continuous basis is expected but may vary depending on the needs of individual PMCF Plans. As long as SOCRATES is active, there is no upper limit to the total number of subjects that may be enrolled, and enrollment will be driven by the need to support sample sizes of individual PMCF plans for given products/product groupings supported by SOCRATES.
SOCRATES is designed to be a continuous effort after the data collection commences without a predefined closure timepoint. Data collection and enrollment may be stopped, restarted or finalized per Sponsor discretion.
The expected duration of SOCRATES participation for a subject is dependent on
- the specific lifetime of the device (e.g. the battery usage for pulse generators or continued active use of leads for CRM devices) or
- the necessary timeframe to adequately assess safety and performance of the device based on the residual risk assessed for each device in the associated PMCF plan. Timeframes might e.g. spread from 7 days to one year post procedure for EP. The maximum duration per enrolled subject will consequently vary.
For BSC implantable devices subjects are intended to be followed for the entire time of being implanted with a BSC device to allow data collection over the lifetime of the device(s) as required by applicable regulations. A maximum duration per enrolled subject is not defined, unless locally required. In case a local maximum duration is enforced subjects may be consented again and re-enrolled for continued participation if they are still in scope for SOCRATES. Sites shall ensure continuous data collection without any gaps in case a re-enrollment becomes applicable. Data sets for re-enrolled subjects will be handled as if the subject was continuously enrolled. This process will ensure to meet the requirement of MDR for device manufacturers to collect data over the lifetime of the devices.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Maria Paz Lopez-Chicharro
- 電話番号:1-800-227-3422
- メール:maria.lopez-chicharro@bsci.com
研究連絡先のバックアップ
- 名前:Jens B Goetzke, Dipl.Ing.
- 電話番号:1-800-227-3422
- メール:Jens.Goetzke@bsci.com
研究場所
-
-
-
Dublin、アイルランド、D07 WKW8
- 募集
- Mater Private Hospital
-
コンタクト:
- Gabor Szeplaki, Prof.
-
-
-
-
-
London、イギリス、EC1A 7BE
- 募集
- St. Bartholomew's Hospital
-
コンタクト:
- Ross Hunter, Prof.
-
Manchester、イギリス、M13 9WL
- 募集
- Manchester Heart Center
-
コンタクト:
- Charles Pearman, MD
-
-
-
-
-
Ramat Gan、イスラエル、52621
- 募集
- Sheba Medical Center
-
コンタクト:
- Roy Beinart, MD
-
Tel Aviv、イスラエル、6423906
- 募集
- Tel Aviv Sourasky Medical Center
-
コンタクト:
- Raphael Rosso, Professor
-
Tel Aviv、イスラエル、62431
- 募集
- Tel Aviv Sourask Medical Center
-
コンタクト:
- Raphael Rosso, Professor
-
-
-
-
-
Modena、イタリア、41124
- 募集
- Policlinico di Modena
-
コンタクト:
- Giuseppe Boriani, Prof.
-
Roma、イタリア、00168
- 募集
- Policlinico Universitario Agostino Gemelli
-
コンタクト:
- Gemma Pelargonio, MD
-
Roma、イタリア、00169
- 募集
- Policlinico Casilino
-
コンタクト:
- Leonardo Calò, MD
-
Roma、イタリア、00186
- 募集
- Ospedale S.G. Calibita Fatebenefratelli - Isola Tiberina
-
コンタクト:
- Stefano Bianchi, MD
-
-
-
-
Quebec
-
Québec、Quebec、カナダ、G1V 4G5
- 募集
- Institut Universitaire de Cardiologie et de Pneumologie de Quebec
-
コンタクト:
- Jean-Francois Sarrazin, MD
-
-
-
-
-
Athens、ギリシャ、17674
- 募集
- Onassis Cardiac Surgery Center
-
コンタクト:
- Michael Ephremidis, MD
-
Athens、ギリシャ、11527
- 完了
- General Hospital of Athens "G. Gennimatas"
-
-
-
-
-
Madrid、スペイン、28040
- 募集
- Hospital Clinico San Carlos
-
コンタクト:
- Nicasio Pérez Castellano, MD
-
San Cristóbal de La Laguna、スペイン、38320
- 募集
- Hospital Universitario de Canarias
-
コンタクト:
- Francisco Bosa Ojeda, MD
-
Santa Cruz de Tenerife、スペイン、38010
- 募集
- Hospital Nuestra Señora de La Candelaria
-
コンタクト:
- Luis A. Acosta, MD
-
Zaragoza、スペイン、50009
- 募集
- Hospital Universitario Miguel Servet
-
コンタクト:
- Antonio Asso Abadía, MD
-
-
-
-
-
Berlin、ドイツ、12687
- 募集
- Unfallkrankenhaus Berlin Marzahn
-
コンタクト:
- Corinna Lenz, MD
-
Bochum、ドイツ、44791
- 完了
- Augusta Kranken Anstalt GmbH
-
-
-
-
-
Brest、フランス、29200
- 募集
- CHRU de Brest, Hôpital de la Cavale Blanche
-
コンタクト:
- Jacques Mansourati, Prof.
-
Clermont-Ferrand、フランス、63000
- 募集
- CHRU de Clermont-Ferrand
-
コンタクト:
- Romain Eschalier, MD
-
Lomme、フランス、59462
- 募集
- Hopital Saint Philibert
-
コンタクト:
- Aymeric Menet, MD
-
Pau、フランス
- 募集
- CHG de Pau
-
コンタクト:
- Hugues Bader, MD
-
Saint-Etienne、フランス、42055
- 募集
- CHU de Saint-Etienne
-
コンタクト:
- Antoine Da Costa, Prof.
-
-
-
-
-
Jette、ベルギー、1090
- 募集
- Universitair Ziekenhuis Brussel
-
コンタクト:
- Carlo de Asmundis, Prof.
-
Yvoir、ベルギー、5530
- 募集
- CHU UCL Namur - Site Godinne
-
コンタクト:
- Dominique Blommaert, Prof.
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
The subjects will be recruited from the general patient population of the participating centers who are
- receiving diagnosis or treatment using a BSC product in scope of SOCRATES and
- fulfilling all inclusion criteria and none of the exclusion criteria.
説明
Inclusion Criteria:
- Subject is willing and capable of providing informed consent and/or to give approval to collect/store/process personal health information by the sponsor or such consent/approval is provided by a legally designated representative, if required by local law or regulation.
- Subject is (one criterion must be fulfilled) a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii. the BSC CRM product implant.
Exclusion Criteria:
- Subject is foreseen not to be followed at the enrolling center for at least 1 year after an implant procedure (CRM) or at least 1 month (EP).
- Subject is receiving diagnosis or therapy by means of any product, that is not approved for commercial use at the time of implant/procedure.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:OTHER
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
BSC Product Use
Subject fulfilling one of the following conditions: a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii.the BSC CRM product implant. |
In the scope of the CRM procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific CRM products/components and combination of those products/components with competitor product(s) per hospital's standard of care. In the scope of the EP procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific Electrophysiology products/components and capital equipment products and combination of those products/components with competitor product(s) per hospital's standard of care. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
System-related complication free rate
時間枠:From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year
|
Freedom from complications related to system |
From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year
|
|
Rate of product related performance deficiencies per product or product group
時間枠:CRM implant on day 0; EP procedure on day 0
|
Performance of product/product group at implant/procedure |
CRM implant on day 0; EP procedure on day 0
|
|
Rate of product related performance deficiencies per product or product group
時間枠:CRM implant on day 0 through the implanted duration up to 10 years
|
Performance of product/product group through the implanted duration |
CRM implant on day 0 through the implanted duration up to 10 years
|
協力者と研究者
捜査官
- スタディディレクター:Eszter Pais, MD、Boston Scientific Corporation
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。